Treta Purohit Goyal, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Office
- 1
Offices
1 location · San Jose Gastroenterology, Inc. · 11 clinicians in this group
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Goyal’s office at (408) 347-9001 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A138479 · Current
Licensed to practise in California · since 2015 · expires 2027-09-30 · Maharashtra University of Health Services, Topiwala National Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$67,242
Medicare paid this office $67,242 for 222 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 89 | $12,470 | $113 |
| New patient visit (45+ min) | 68 | $10,304 | $152 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 40 | $9,305 | $227 |
| Pathology examination of tissue using a microscope, intermediate complexity | 84 | $7,139 | $40 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 48 | $3,833 | $78 |
See all 13 services
| Return visit (30+ min) | 89 | $12,470 | $113 |
| New patient visit (45+ min) | 68 | $10,304 | $152 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 40 | $9,305 | $227 |
| Pathology examination of tissue using a microscope, intermediate complexity | 84 | $7,139 | $40 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 48 | $3,833 | $78 |
| Biopsy of large bowel using a flexible endoscope | 37 | $3,685 | $97 |
| Short return visit (20+ min) | 34 | $3,036 | $78 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,880 | $206 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $2,879 | $160 |
| Long return visit (40+ min) | 13 | $2,239 | $172 |
| Special stained specimen slides to identify organisms including interpretation and report | 12 | $2,041 | $97 |
| New patient visit (30+ min) | 16 | $1,153 | $72 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 13 | $57 | $4 |
Procedures Medicare counted
| Colonoscopy | 70 | More than 71% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 31 | More than 56% of doctors who do this |
Who their Medicare patients are
222 Original Medicare patients in 2024. Average age 73 · Women 61% · Also on Medicaid 55% · Health risk score 1.32. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 40% · Coronary heart disease 20% · Chronic kidney disease 19% · Depression 14% · Heart failure 13% · Cancer 11% · COPD 9% · Atrial fibrillation 9% · Stroke 6% · Dementia 5%.
The office billed $340,927, Medicare allowed $87,134 and paid $67,242; for 659 services of 28 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 222 | 659 | 73 | 1.32 | $340,927 | $67,242 |
| 2023 | 203 | 707 | 73 | 0.97 | $250,912 | $64,875 |
| 2022 | 267 | 862 | 74 | 1.10 | $318,463 | $84,335 |
| 2021 | 147 | 492 | 72 | 1.21 | $169,560 | $46,987 |
| 2020 | 171 | 474 | 73 | 1.81 | $169,104 | $53,719 |
| 2019 | 334 | 1,062 | 73 | 1.74 | $392,460 | $116,384 |
| 2018 | 278 | 887 | 72 | 1.51 | $348,320 | $92,720 |
| 2017 | 282 | 738 | 71 | 1.39 | $446,508 | $72,657 |
| 2016 | 102 | 162 | 71 | 1.17 | $181,220 | $20,735 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 42 | $9,968 | $232 |
| Pathology examination of tissue using a microscope, intermediate complexity | 96 | $8,623 | $39 |
| Short return visit (20+ min) | 63 | $6,702 | $82 |
| New patient visit (45+ min) | 42 | $6,188 | $147 |
| Biopsy of large bowel using a flexible endoscope | 47 | $4,993 | $104 |
| Diagnostic exam of large bowel using a flexible endoscope | 31 | $4,921 | $159 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 54 | $4,754 | $86 |
| Return visit (30+ min) | 26 | $3,963 | $120 |
| Special stained specimen slides to identify organisms including interpretation and report | 15 | $2,697 | $96 |
| New patient visit (30+ min) | 20 | $1,711 | $86 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 28 | $140 | $5 |
2022: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 52 | $12,051 | $232 |
| New patient visit (45+ min) | 77 | $11,039 | $143 |
| Pathology examination of tissue using a microscope, intermediate complexity | 105 | $8,353 | $38 |
| Short return visit (20+ min) | 66 | $8,167 | $82 |
| Biopsy of large bowel using a flexible endoscope | 60 | $5,771 | $96 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 60 | $5,304 | $86 |
| Return visit (30+ min) | 31 | $4,260 | $122 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $4,216 | $211 |
| New patient visit (30+ min) | 37 | $3,478 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,405 | $179 |
| Special stained specimen slides to identify organisms including interpretation and report | 16 | $2,306 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,235 | $93 |
| Complete ultrasound scan of abdomen | 18 | $2,155 | $113 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,934 | $161 |
| New patient visit (15+ min) | 15 | $1,047 | $70 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 27 | $123 | $5 |
2021: 10 services
| Short return visit (20+ min) | 49 | $6,649 | $87 |
| New patient visit (45+ min) | 40 | $6,172 | $154 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 25 | $5,872 | $235 |
| Pathology examination of tissue using a microscope, intermediate complexity | 53 | $4,350 | $37 |
| Return visit (30+ min) | 20 | $3,024 | $126 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,999 | $214 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 30 | $2,902 | $97 |
| Biopsy of large bowel using a flexible endoscope | 33 | $2,711 | $82 |
| New patient visit (30+ min) | 23 | $2,464 | $107 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 15 | $72 | $5 |
2020: 10 services
| New patient visit (45+ min) | 64 | $9,376 | $147 |
| Return visit (30+ min) | 39 | $4,947 | $101 |
| Pathology examination of tissue using a microscope, intermediate complexity | 50 | $4,167 | $50 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,742 | $178 |
| Biopsy of large bowel using a flexible endoscope | 30 | $3,739 | $125 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 31 | $3,392 | $106 |
| Short return visit (20+ min) | 35 | $3,314 | $71 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $3,236 | $231 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,308 | $96 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 19 | $93 | $5 |
2019: 15 services
| New patient visit (45+ min) | 120 | $17,649 | $147 |
| Pathology examination of tissue using a microscope, intermediate complexity | 100 | $14,083 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $10,303 | $181 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 40 | $9,254 | $226 |
| Return visit (30+ min) | 66 | $8,742 | $97 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 86 | $8,471 | $96 |
| Biopsy of large bowel using a flexible endoscope | 61 | $6,077 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $5,392 | $93 |
| Special stained specimen slides to identify organisms including interpretation and report | 41 | $5,283 | $104 |
| Short return visit (20+ min) | 50 | $4,308 | $71 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 16 | $3,389 | $212 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,530 | $102 |
| Special stained specimen slides to examine tissue, initial procedure | 11 | $1,199 | $109 |
| New patient visit (10+ min) | 22 | $886 | $40 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 39 | $187 | $5 |
2018: 17 services
| New patient visit (45+ min) | 84 | $12,335 | $147 |
| Pathology examination of tissue using a microscope, intermediate complexity | 59 | $9,305 | $68 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 37 | $8,902 | $234 |
| Biopsy of large bowel using a flexible endoscope | 70 | $8,409 | $118 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 89 | $7,235 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $6,367 | $182 |
| Return visit (30+ min) | 43 | $4,997 | $100 |
| Short return visit (20+ min) | 50 | $4,430 | $66 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $3,799 | $190 |
| New patient visit (30+ min) | 43 | $3,595 | $84 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,552 | $213 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,528 | $94 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $2,042 | $170 |
| Special stained specimen slides to identify organisms including interpretation and report | 16 | $1,814 | $101 |
| Microscopic genetic analysis of tumor, manual | 12 | $1,513 | $126 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 22 | $289 | $10 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 39 | $178 | $5 |
2017: 14 services
| New patient visit (45+ min) | 78 | $10,354 | $133 |
| Biopsy of large bowel using a flexible endoscope | 83 | $10,035 | $121 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 31 | $6,907 | $223 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 66 | $5,679 | $82 |
| Pathology examination of tissue using a microscope, intermediate complexity | 34 | $5,321 | $67 |
| New patient visit (30+ min) | 49 | $3,750 | $77 |
| Return visit (30+ min) | 32 | $2,698 | $75 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $2,638 | $147 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 13 | $2,559 | $197 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,538 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,853 | $88 |
| Short return visit (20+ min) | 22 | $1,544 | $64 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 53 | $258 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 19 | $219 | $12 |
2016: 5 services
| Biopsy of large bowel using a flexible endoscope | 24 | $3,588 | $150 |
| New patient visit (45+ min) | 24 | $3,101 | $129 |
| Long return visit (40+ min) | 17 | $2,254 | $119 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $1,951 | $89 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $980 | $82 |
Medicaid work
$120 in 2024
Medicaid paid $120 for 83 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Upper gastrointestinal endoscopy with biopsy | 12 | $120 |
| TISSUE EXAM BY PATHOLOGIST | 22 | $0 |
| New patient visit (30+ min) | 13 | $0 |
| New patient visit (45+ min) | 14 | $0 |
| Return visit (30+ min) | 22 | $0 |
| 2024 | 83 | 5 | 22 | $120 |
| 2023 | 39 | 1 | 14 | $0 |
| 2022 | 112 | 3 | 18 | $476 |
| 2021 | 24 | 1 | 12 | $0 |
| 2019 | 38 | 1 | 14 | $519 |
| 2018 | 80 | 4 | 15 | $1,734 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 39 | $0 |
2022
| Upper gastrointestinal endoscopy with biopsy | 31 | $365 |
| Short return visit (20+ min) | 41 | $111 |
| TISSUE EXAM BY PATHOLOGIST | 40 | $0 |
2021
| Short return visit (20+ min) | 24 | $0 |
2019
| Upper gastrointestinal endoscopy with biopsy | 38 | $519 |
2018
| Upper gastrointestinal endoscopy with biopsy | 37 | $1,243 |
| COLONOSCOPY AND BIOPSY | 15 | $464 |
| Short return visit (20+ min) | 16 | $26 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 12 | $0 |
Drugs they prescribed that Part D paid
$162,389
Pharmacies billed $162,389 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 622) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
497 generic and 125 brand-name prescriptions · $162,389 in drug cost · 35 antibiotic prescriptions to 20 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 29 | $46,806 | $1,614 |
| Linzess | 11 | $14,001 | $1,273 |
| Sod Sulf-Potass Sulf-Mag Sulf | 42 | $2,537 | $60 |
| Gavilyte-G | 111 | $1,579 | $14 |
| Pantoprazole | 92 | $1,373 | $15 |
See all 12 drugs
| Vemlidy | 29 | $46,806 | $1,614 |
| Linzess | 11 | $14,001 | $1,273 |
| Sod Sulf-Potass Sulf-Mag Sulf | 42 | $2,537 | $60 |
| Gavilyte-G | 111 | $1,579 | $14 |
| Pantoprazole | 92 | $1,373 | $15 |
| Gavilyte-C | 36 | $728 | $20 |
| Omeprazole | 71 | $662 | $9 |
| Peg 3350-Electrolyte | 18 | $457 | $25 |
| Peg-3350 and Electrolytes | 30 | $430 | $14 |
| Ondansetron Odt | 11 | $420 | $38 |
| Famotidine | 20 | $273 | $14 |
| Hydrocortisone | 14 | $56 | $4 |
Year by year
| 2024 | 622 | 322 | 0% (0) | 20% | $162,389 |
| 2023 | 531 | 236 | 0% (0) | 22% | $226,550 |
| 2022 | 605 | 266 | 0% (0) | 36% | $280,618 |
| 2021 | 441 | 206 | 0% (0) | 42% | $151,063 |
| 2020 | 432 | 182 | 0% (0) | 36% | $103,375 |
| 2019 | 570 | 278 | 0% (0) | 30% | $162,866 |
| 2018 | 501 | 227 | 0% (0) | 30% | $160,947 |
| 2017 | 342 | 161 | 0% (0) | 41% | $78,871 |
| 2016 | 145 | 67 | 0% (0) | 23% | $49,166 |
| 2015 | 63 | 22 | None | 27% | $33,675 |
| 2014 | 35 | 17 | 0% (0) | None | $609 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Vemlidy | 35 | $53,014 | $1,515 |
| Linzess | 21 | $20,543 | $978 |
| Sod Sulf-Potass Sulf-Mag Sulf | 28 | $2,202 | $79 |
| Pantoprazole | 98 | $1,675 | $17 |
| Omeprazole | 73 | $1,569 | $21 |
| Gavilyte-G | 84 | $1,491 | $18 |
| Famotidine | 27 | $460 | $17 |
| Dicyclomine | 19 | $371 | $20 |
| Peg-3350 and Electrolytes | 13 | $233 | $18 |
| Metronidazole | 13 | $222 | $17 |
2022: 14 drugs
| Vemlidy | 25 | $34,242 | $1,370 |
| Linzess | 34 | $23,308 | $686 |
| Xifaxan | 11 | $23,307 | $2,119 |
| Dexilant | 12 | $7,817 | $651 |
| Suprep | 49 | $5,609 | $114 |
| Omeprazole | 94 | $1,536 | $16 |
| Pantoprazole | 89 | $1,319 | $15 |
| Gavilyte-G | 61 | $861 | $14 |
| Peg-3350 and Electrolytes | 44 | $632 | $14 |
| Famotidine | 36 | $616 | $17 |
| Peg 3350-Electrolyte | 13 | $272 | $21 |
| Gavilyte-C | 15 | $261 | $17 |
| Dicyclomine | 13 | $221 | $17 |
| Constulose | 11 | $68 | $6 |
2021: 12 drugs
| Vemlidy | 33 | $42,064 | $1,275 |
| Linzess | 13 | $13,113 | $1,009 |
| Suprep | 64 | $6,946 | $109 |
| Trulance | 13 | $6,450 | $496 |
| Dexilant | 13 | $6,414 | $493 |
| Omeprazole | 97 | $1,058 | $11 |
| Pantoprazole | 26 | $456 | $18 |
| Peg 3350-Electrolyte | 13 | $235 | $18 |
| Famotidine | 13 | $186 | $14 |
| Peg-3350 and Electrolytes | 15 | $184 | $12 |
| Gavilyte-G | 13 | $132 | $10 |
| Constulose | 12 | $30 | $2 |
2020: 9 drugs
| Vemlidy | 27 | $32,075 | $1,188 |
| Linzess | 22 | $23,741 | $1,079 |
| Trulance | 13 | $7,283 | $560 |
| Suprep | 45 | $4,691 | $104 |
| Omeprazole | 105 | $1,253 | $12 |
| Gavilyte-G | 31 | $403 | $13 |
| Dicyclomine | 13 | $303 | $23 |
| Pantoprazole | 21 | $229 | $11 |
| Famotidine | 16 | $213 | $13 |
2019: 14 drugs
| Vemlidy | 21 | $23,731 | $1,130 |
| Linzess | 21 | $18,681 | $890 |
| Suprep | 60 | $5,870 | $98 |
| Omeprazole | 132 | $1,356 | $10 |
| Gavilyte-G | 71 | $1,027 | $14 |
| Clarithromycin | 16 | $691 | $43 |
| Gavilyte-N | 13 | $246 | $19 |
| Metronidazole | 20 | $245 | $12 |
| Amoxicillin | 21 | $237 | $11 |
| Dicyclomine | 13 | $237 | $18 |
| Peg 3350-Electrolyte | 13 | $205 | $16 |
| Peg-3350 and Electrolytes | 16 | $200 | $12 |
| Pantoprazole | 12 | $143 | $12 |
| Metoclopramide | 13 | $103 | $8 |
2018: 10 drugs
| Vemlidy | 19 | $19,771 | $1,041 |
| Trulance | 13 | $9,700 | $746 |
| Suprep | 30 | $2,706 | $90 |
| Omeprazole | 119 | $1,342 | $11 |
| Peg 3350-Electrolyte | 55 | $959 | $17 |
| Gavilyte-N | 30 | $574 | $19 |
| Gavilyte-G | 31 | $380 | $12 |
| Amoxicillin | 22 | $175 | $8 |
| Ranitidine | 16 | $148 | $9 |
| Levofloxacin | 19 | $116 | $6 |
2017: 7 drugs
| Delzicol | 29 | $5,750 | $198 |
| Suprep | 51 | $4,427 | $87 |
| Omeprazole | 76 | $611 | $8 |
| Peg 3350-Electrolyte | 22 | $329 | $15 |
| Gavilyte-G | 15 | $189 | $13 |
| Pantoprazole | 18 | $169 | $9 |
| Ranitidine | 11 | $84 | $8 |
2016: 2 drugs
| Omeprazole | 41 | $255 | $6 |
| Peg-3350 and Electrolytes | 12 | $144 | $12 |
2015: 1 drug
| Omeprazole | 19 | $226 | $12 |
Money from drug and device companies
$378 in 2025
| 2025 | 7 | 15 | None | $378 |
| 2024 | 6 | 6 | None | $126 |
| 2023 | 3 | 6 | None | $120 |
| 2022 | 3 | 5 | None | $100 |
| 2021 | 1 | 11 | None | $183 |
| 2020 | 1 | 1 | None | $12 |
| 2019 | 2 | 2 | None | $142 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Madrigal Pharmaceuticals | Rezdiffra | $149 | 5 payments
|
| Abbvie | Creon | $78 | 4 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $46 | 2 payments
|
| Lilly USA | Omvoh | $33 | 1 payment
|
| Gilead Sciences | None | $28 | 1 payment
|
| Vivus | Pancreaze | $22 | 1 payment
|
See all 15 published payments
| Madrigal Pharmaceuticals | Meals · 2025-11-18 | Rezdiffra | $45 |
| Madrigal Pharmaceuticals | Meals · 2025-11-18 | Rezdiffra | $3 |
| Abbvie | Meals · 2025-10-16 | Creon | $20 |
| Madrigal Pharmaceuticals | Meals · 2025-10-15 | Rezdiffra | $49 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-10-13 | Xifaxan | $24 |
| Abbvie | Meals · 2025-09-11 | Linzess | $15 |
| Braintree Laboratories | Meals · 2025-09-03 | Suflave | $21 |
| Madrigal Pharmaceuticals | Meals · 2025-08-19 | Rezdiffra | $21 |
| Abbvie | Meals · 2025-08-08 | Linzess | $20 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-08-04 | Xifaxan | $23 |
| Abbvie | Meals · 2025-05-22 | Creon | $23 |
| Vivus | Meals · 2025-04-15 | Pancreaze | $22 |
| Lilly USA | Meals · 2025-04-08 | Omvoh | $33 |
| Madrigal Pharmaceuticals | Meals · 2025-04-02 | Rezdiffra | $33 |
| Gilead Sciences | Meals · 2025-02-06 | None | $28 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $126
| Janssen Biotech | Stelara | $29 | 1 payment
|
| Lilly USA | Omvoh | $28 | 1 payment
|
| Abbvie | Mavyret | $24 | 1 payment
|
| Braintree Laboratories | Sutab | $17 | 1 payment
|
| Lucid Diagnostics | None | $14 | 1 payment
|
| Gilead Sciences | None | $13 | 1 payment
|
2023: $120
| Abbvie | Mavyret | $81 | 4 payments
|
| Pfizer | Xeljanz | $21 | 1 payment
|
| Gilead Sciences | None | $18 | 1 payment
|
2022: $100
| Gilead Sciences | None | $56 | 3 payments
|
| Lucid Diagnostics | None | $23 | 1 payment
|
| Abbvie | Mavyret | $21 | 1 payment
|
2021: $183
| Gilead Sciences | None | $183 | 11 payments
|
2020: $12
| Gilead Sciences | None | $12 | 1 payment
|
2019: $142
| Teva Pharmaceuticals USA | Ajovy | $125 | 1 payment
|
| Allergan | Linzess | $17 | 1 payment
|
Professional record
- NPI
- 1558612770
- Licence
- CA A138479California A138479: Current · expires 2027-09-30
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Student in a training program (390200000X)
- Mailing address
- 2331 Montpelier Dr, Ste B, San Jose, CA, 95116
- NPI first listed
- 2012-09-27
- NPI last updated
- 2017-05-08
This is when the NPI record was last certified, not a medical board exam.